BioSpace News Archive

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Numerous biopharmaceutical companies and researchers are presenting research and clinical trial results, and many have been announcing their plans for several weeks.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 29, 2020.

In a paper published on Wednesday, Denali detailed the engineering of its transport vehicles.

CordenPharma, a full-service Contract Development & Manufacturing Organization for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients.

Oncopeptides AB announces that the company starts patient enrollment to its clinical program following the temporary recruitment pause due to the COVID-19 pandemic, announced on March 20.

Australian scientists have revealed that a natural compound found in seaweed may reduce the effects of severe cases of Influenza A.

ATR-002 mode of action inhibits SARS-CoV-2 viral propagation and prevents the cytokine storm as demonstrated in preclinical studies

Upper respiratory tract infection is a medical condition caused by acute infection that involves parts of the upper respiratory tract such as larynx or pharynx, sinuses, and nose.

The global spine surgery products market is expected in a report by Transparency Market Research to find companies focusing on mergers and acquisitions, expansion of regional footprint, and diversification of product portfolio to stay in a strong position.